158 related articles for article (PubMed ID: 12597640)
1. European Working Group on Clinical Cell Analysis (EWGCCA): 6 years on.
Papa S;
J Biol Regul Homeost Agents; 2002; 16(4):253-6. PubMed ID: 12597640
[No Abstract] [Full Text] [Related]
2. Clinical Cytometry on both sides of the Atlantic, 2011.
Preffer FI; Gratama JW
Cytometry B Clin Cytom; 2011 Nov; 80(6):373-4. PubMed ID: 22002905
[No Abstract] [Full Text] [Related]
3. Setting up and calibration of a flow cytometer for multicolor immunophenotyping.
Kraan J; Gratama JW; Keeney M; D'Hautcourt JL
J Biol Regul Homeost Agents; 2003; 17(3):223-33. PubMed ID: 14524607
[No Abstract] [Full Text] [Related]
4. Validation and quality control of immunophenotyping in clinical flow cytometry.
Owens MA; Vall HG; Hurley AA; Wormsley SB
J Immunol Methods; 2000 Sep; 243(1-2):33-50. PubMed ID: 10986405
[TBL] [Abstract][Full Text] [Related]
5. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia.
Wood BL; Arroz M; Barnett D; DiGiuseppe J; Greig B; Kussick SJ; Oldaker T; Shenkin M; Stone E; Wallace P
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S14-22. PubMed ID: 17803189
[TBL] [Abstract][Full Text] [Related]
6. Guideline for flow cytometric immunophenotyping: a report from the National Institute of Allergy and Infectious Diseases, Division of AIDS.
Calvelli T; Denny TN; Paxton H; Gelman R; Kagan J
Cytometry; 1993 Oct; 14(7):702-15. PubMed ID: 8243200
[No Abstract] [Full Text] [Related]
7. Consensus report of the task force on standardisation of DNA flow cytometry in clinical pathology. DNA Flow Cytometry Task Force of the European Society for Analytical Cellular Pathology.
Ormerod MG; Tribukait B; Giaretti W
Anal Cell Pathol; 1998; 17(2):103-10. PubMed ID: 10052634
[TBL] [Abstract][Full Text] [Related]
8. Immunophenotypic characterization of CD34(pos) cells.
Keeney M; Brown W; Gratama J; Papa S; Lanza F; Sutherland DR;
J Biol Regul Homeost Agents; 2003; 17(3):254-60. PubMed ID: 14524611
[No Abstract] [Full Text] [Related]
9. Towards standardization in immunophenotyping hematological malignancies. How can we improve the reproducibility and comparability of flow cytometric results? Working Group on Leukemia Immunophenotyping.
Lanza F
Eur J Histochem; 1996; 40 Suppl 1():7-14. PubMed ID: 8839695
[No Abstract] [Full Text] [Related]
10. Torture prevention in practice. Association for the Prevention of Torture.
Delaplace E; Pollard M
Torture; 2006; 16(3):220-46. PubMed ID: 17251651
[No Abstract] [Full Text] [Related]
11. In the realm for standardization in immunophenotyping.
Tárnok A
Cytometry A; 2012 Nov; 81(11):931-2. PubMed ID: 23090894
[No Abstract] [Full Text] [Related]
12. Influence of 4- and 6-color flow cytometers and acquisition/analysis softwares on the determination of lymphocyte subsets in HIV infection.
Ashman M; Sachdeva N; Davila L; Scott G; Mitchell C; Cintron L; Rathore M; Asthana D
Cytometry B Clin Cytom; 2007 Sep; 72(5):380-6. PubMed ID: 17226862
[TBL] [Abstract][Full Text] [Related]
13. EuroFlow and its activities: Introduction to the special EuroFlow issue of The Journal of Immunological Methods.
van Dongen JJM; O'Gorman MRG; Orfao A
J Immunol Methods; 2019 Dec; 475():112704. PubMed ID: 31758969
[No Abstract] [Full Text] [Related]
14. Flow Cytometry in Transplantation.
Hutchinson JA
Transplantation; 2015 Jul; 99(7):1308-9. PubMed ID: 26147134
[No Abstract] [Full Text] [Related]
15. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
[TBL] [Abstract][Full Text] [Related]
16. Harmonemia: a universal strategy for flow cytometry immunophenotyping-A European LeukemiaNet WP10 study.
Lacombe F; Bernal E; Bloxham D; Couzens S; Porta MG; Johansson U; Kern W; Macey M; Matthes T; Morilla R; Paiva A; Palacio C; Preijers F; Ratei R; Siitonen S; Allou K; Porwit A; Béné MC
Leukemia; 2016 Aug; 30(8):1769-72. PubMed ID: 26922887
[No Abstract] [Full Text] [Related]
17. Pitfalls of CD45 gating strategies in leukaemia immunophenotyping.
Lock RJ; Virgo PF; Evely RS
Clin Lab Haematol; 2003 Feb; 25(1):67. PubMed ID: 12542446
[No Abstract] [Full Text] [Related]
18. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures.
Stelzer GT; Marti G; Hurley A; McCoy P; Lovett EJ; Schwartz A
Cytometry; 1997 Oct; 30(5):214-30. PubMed ID: 9383095
[No Abstract] [Full Text] [Related]
19. U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations.
Stewart CC; Behm FG; Carey JL; Cornbleet J; Duque RE; Hudnall SD; Hurtubise PE; Loken M; Tubbs RR; Wormsley S
Cytometry; 1997 Oct; 30(5):231-5. PubMed ID: 9383096
[No Abstract] [Full Text] [Related]
20. Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA).
Barnett D; Granger V; Kraan J; Whitby L; Reilly JT; Papa S; Gratama JW
Br J Haematol; 2000 Mar; 108(4):784-92. PubMed ID: 10792284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
